BUKWANG PHARM to invest 24.5B KRW in automated warehouse
부광약품
003000
Signal Score
Historical Avg Return (5d)
+0.41%
Data Coverage
20%n=59
Risk-adjusted indicator based on 59 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Acquisition Amount: 24,495,000,000 KRW
- • Total Assets: 476,294,610,331 KRW (as of 2025)
- • Investment as % of Total Assets: 5.14%
- • Scheduled Acquisition Date: November 30, 2027
- • Board Resolution Date: August 26, 2026
AI Analysis Summary
BUKWANG PHARM has decided to acquire tangible assets, specifically an automated warehouse, for 24.495 billion KRW. This investment, representing 5.14% of total assets (as of 2025), aims to improve logistics facilities and operational efficiency. The new warehouse will be constructed on existing factory land, with completion expected by November 30, 2027. This CAPEX is a positive signal for long-term efficiency and capacity.
How This Event Is Evaluated
Capital Investment Evaluation
Capital investment events are evaluated by measuring investment size relative to company scale, expected return, and funding source.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Investment size relative to company assets
- Expected capacity or revenue impact
- Funding source and balance sheet impact
- Execution timeline
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.